Seed · Biotech · Cambridge, United Kingdom · Founded 2023
CamGene Therapeutics is a biotechnology company developing first-in-class, RNA-based medicines to treat hearing loss. The company's proprietary lipid nanoparticle delivery platform targets cells in the inner ear to modulate protein expression and prevent cellular dysfunction. In October 2025, the firm secured a 3.6 million GBP seed round to advance its platform, which is designed to initially deliver therapies alongside cochlear implant surgery. Backed by specialized life science investors and academic venture funds, the startup operates from the Mill SciTech Park incubator in Cambridge.
No open roles listed right now.